Synthetic methods and for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

A product, methoxypiperidine technology, applied in organic chemistry and other directions, can solve problems such as limitations and adverse drug interactions, and achieve the effect of reducing adverse reactions, low incidence of side effects and toxicity, and safe drug metabolism process.

Active Publication Date: 2012-10-10
雷内克新有限责任公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because of these adverse reactions, the drug was automatically withdrawn from the U.S. open market; however, the drug remains available through an investigational limited eligibility program
[0016] 5HT with gastrointestinal (GI) prokinetic activity 4 Safety of agonists is limited by cardiac effects (QT prolongation, tachycardia, and torsades de pointes) and adverse drug interactions due to hepatic cytochrome P-450 metabolism

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic methods and for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
  • Synthetic methods and for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
  • Synthetic methods and for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0305] Compound preparation

[0306] Although the chemical synthesis of various analogs of cisapride can be carried out according to European Patent Application No. 0,076,530 A2 published on April 13, 1983, WO 01 / 093849, U.S. Patent No. 4,962,115, No. 5,057,525 and Van Daele et al., Drug Development Res. 8:225-232 (1986) (the content of which is incorporated herein by reference in its entirety), the compounds of the present invention are preferably prepared according to the disclosure of Methods 3-6.

Embodiment 1

[0483] 6-[4R-(4-Amino-5-chloro-2-methoxy-benzamido)-3S-methoxy-piperidin-1-yl]-hexanoic acid

[0484] Preparation of 1-aza-bicyclo[2.2.2]oct-3′R-yl ester dihydrochloride

[0485]

[0486] Step 1: Resolution of racemic norcisapride

[0487] (-)-2,3-Dibenzoyl-L-tartaric acid ((-)-DBT, about 1 part by weight) was dissolved in ethanol and filtered to remove residual particles. Separately, racemic norcisapride (approximately 0.8 parts by weight) was dissolved in a mixture of ethanol and water and filtered. The filtrate was heated to about 75°C, and then the (-)-DBT solution was added. After stirring at this temperature for about 30 minutes, the mixture was cooled slowly to about 5 °C for several hours, and the product salt was collected by vacuum filtration and washed with EtOH / H 2 O mixture wash. The filter cake was removed from EtOH / H by heating to about 79°C and then slowly cooling to about 2 recrystallized from O. The product was collected on a vacuum filter ...

example 2

[0496] According to U.S. Patent No. 6,147,093, or "Enantiomaers, Racemates and Resolutions" by J. Jacques, A. Collet and S.H. Wilen (Wiley-Interscience, New York, NY) (Enantiomers, Racemates and Resolutions) separation), or by the method described in S.H.Wilen et al., Tetrahedron (1977) 33:2725, by resolution of enantiomers using conventional means such as optical resolution acids, can be prepared from their racemic mixture ( +) and (-)-norcisapride.

[0497] The 4 isomers were obtained in low amounts (mg) by preparative column chromatography followed by evaporation of the solvent. This method can be used to prepare small amounts of isomers for analysis and identification purposes. This is a standard separation method routinely used by analytical laboratories to isolate and identify metabolites.

[0498] The possible routes for the synthesis of compound IV, compound VI and (+)-compound II using (+)-norcisapride as starting materials are described below. Except for using (-)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The subject invention provides methods and / or processes for making stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.

Description

[0001] This application claims priority to US Provisional Application No. 60 / 713,149, filed August 31, 2005, and US Provisional Application No. 60 / 747,762, filed May 19, 2006. Background technique [0002] Cisapride is one of a class of compounds known as benzamide derivatives, whose parent compound is metoclopramide. US Patent Nos. 4,962,115 and 5,057,525 (collectively "Van Daele" and incorporated herein by reference in their entirety) disclose N-(3-hydroxy-4-piperidinyl)benzamides of cisapride. Van Daele discloses that these compounds and their pharmaceutically acceptable acid addition salts and their stereoisomeric forms stimulate the motility of the gastrointestinal system. [0003] As a class of compounds, these benzamide derivatives have several remarkable pharmacological effects. The pronounced pharmacological activity of benzamide derivatives is attributed to their effects on the nervous system regulated by the neurotransmitter serotonin. It has been generally accept...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D453/02C07D211/58
CPCY02P20/55
Inventor K·比J·B·叶P·彭
Owner 雷内克新有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap